General
Preferred name
PROMETHAZINE
Synonyms
PROMETHAZINE HYDROCHLORIDE ()
Proazamine ()
Diphergan ()
Promethazine (HCl) ()
(±)-Promethazine ()
Phenergan58-33-3 ()
Promethazine (hydrochloride) ()
Promethazine HCl ()
Promethegan ()
Zipan-25 ()
Promethacon ()
Phensedyl ()
Prometh Fortis ()
Phenergan ()
Prometh Plain ()
Phenergan Nightime ()
Phenhalal ()
Zipan-50 ()
Q-Mazine ()
Promethazine Hydrochloride Plain ()
Sominex ()
Mymethazine Fortis ()
Promethazine Plain ()
Sarantihist ()
Remsed ()
Procit ()
Prothazin ()
NSC-30321 ()
RP-3277 ()
Dimapp ()
Fargan ()
Prometazina ()
Protazine ()
Vallergine ()
Prometazin ()
Promethazine ()
Promethazine (hydrochloride) (CRM) ()
Promethazine-d4 (hydrochloride) ()
Promethazine-d3 (hydrochloride) ()
Promethazine-d3 (hydrochloride) (CRM) ()
P&D ID
PD009828
CAS
58-33-3
60-87-7
16639-38-6
38878-40-9
1173018-74-0
1435933-86-0
Tags
available
nuisance
drug
Approved by
FDA
First approval
1951
Drug indication
Middle East Respiratory Syndrome (MERS)
Antihistaminic
Nausea
Severe acute respiratory syndrome (SARS)
Anti-Emetic
Drug Status
approved
investigational
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
This drug is a first-generation antihistamine with strong sedative and weak antipsychotic effects. Additional properties include antiemetic and anticholinergic actions.
(GtoPdb)
DESCRIPTION
H1 Histamine receptor antagonist; anticholinergic
(LOPAC library)
DESCRIPTION
Promethazine hydrochloride is first-generation antihistamine of the phenothiazine family used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals. It shows an effect against allergy via inhibiting histamine H1.
(BOC Sciences Bioactive Compounds)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
1
Organisms
2
Compound Sets
32
BOC Sciences Bioactive Compounds
ChEMBL Approved Drugs
ChEMBL Drugs
Concise Guide to Pharmacology 2017/18
Concise Guide to Pharmacology 2019/20
Concise Guide to Pharmacology 2021/22
Concise Guide to Pharmacology 2023/24
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
Ki Database
LOPAC library
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Nuisance compounds in cellular assays
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
79
Molecular Weight
284.13
Hydrogen Bond Acceptors
3
Hydrogen Bond Donors
0
Rotatable Bonds
3
Ring Count
3
Aromatic Ring Count
2
cLogP
4.24
TPSA
6.48
Fraction CSP3
0.29
Chiral centers
1.0
Largest ring
6.0
QED
0.83
Structural alerts
1
CAD
Nuisance compounds
Custom attributes
(extracted from source data)
Selectivity
H1
Pathway
GPCR/G protein
Neuroscience
Immunology/Inflammation
Neuronal Signaling
Target
5-HT
mAChR
Adrenergic Receptor
CAM
D2
H1 receptor
HRH1
Histamine Receptor
Indication
sedative, allergic rhinitis
Disease Area
neurology/psychiatry, allergy
MOA
Histamine Receptor antagonist
Therapeutic Class
Antiallergic Agents
Antiviral Agents
Solubility
Soluble in DMSO
Source data